Thionucleoside Stabilization of Luminogenic Substrates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Luminogenic substrates used in biological assays are prone to decomposition during storage, leading to reduced sensitivity and reproducibility of luminescent measurements, as they are unstable in solution over time and can be affected by temperature and light exposure.
Innovation Solution
A composition comprising a luminogenic substrate, a thionucleoside of formula (I) or its tautomer, and an organic solvent, which stabilizes the substrate against decomposition by suppressing the formation of decomposition products, thereby extending its half-life and maintaining its stability across various temperatures and light conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If luminogenic substrate is stored in solution, then it is readily available for use in assays, but it decomposes over time resulting in loss of substrate and reduced sensitivity
Solution Approach 1:
The patent introduces an intermediary substance (e.g., bovine serum albumin or other stabilizing agents) that mediates between the luminogenic substrate and the aqueous environment, preventing direct interaction that causes decomposition. This intermediary protects the substrate while maintaining its availability in solution.
Solution Approach 2:
The patent modifies the chemical parameters of the storage solution by adding stabilizing compounds, adjusting pH, ionic strength, or other solution properties to create an environment where the luminogenic substrate remains stable over extended periods without requiring freezing or other extreme conditions.
2Measurement precision
If luminogenic substrate concentration is increased to improve assay sensitivity, then signal strength increases, but decomposition rate increases leading to more inhibition products
Solution Approach 1:
The stabilizing agent acts as a mediator that allows higher substrate concentrations to be maintained without proportionally increased decomposition. It intercepts degradation pathways, enabling the system to achieve higher sensitivity while controlling the formation of inhibitory decomposition products.
3Reliability
If storage temperature is reduced to stabilize luminogenic substrate, then decomposition is slowed, but substrate availability and assay workflow are compromised
Solution Approach 1:
The patent changes the chemical parameters of the storage medium to achieve stabilization at higher temperatures. By incorporating stabilizing compounds, the substrate remains stable at refrigerator or even room temperature, eliminating the need for freezing and enabling faster thawing and assay preparation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively stabilizes luminogenic substrates like coelenterazine and furimazine, significantly increasing their half-life and maintaining their stability in the presence or absence of light, at different temperatures, thus enhancing the reliability and sensitivity of luminescent assays.
Implementation Method 1
the compound of formula (I) or tautomer thereof stabilizes the luminogenic substrate
Implementation Method 2
Luminescence is often used in biological assays as a measure of the activity of a reporter molecule
Data Source
Figure 1A
Figure 1B
Figure 2A
AI summary
Disclosed herein are compositions and methods for stabilizing a luminogenic substrate such as coelenterazine or a functional analog thereof. The functional analog may be furimazine. The composition may include the luminogenic substrate, a thionucleoside, and an organic solvent, in which the thionucleoside is present in an amount effective to stabilize the luminogenic composition against decomposition. The method provided herein stabilizes the luminogenic substrate against decomposition by contacting the luminogenic substrate with an effective amount of the thionucleoside in the presence of the organic solvent. Also provided herein is a kit containing the composition.